Shares of Rheinmetall AG Unsponsored ADR (OTCMKTS:RNMBY – Get Free Report) saw unusually-high trading volume on Monday . 116,077 shares changed hands during trading, an increase of 47% from the previous session’s volume of 78,900 shares.The stock last traded at $223.70 and had previously closed at $226.95.
Analysts Set New Price Targets
A number of research analysts have issued reports on the stock. Citigroup raised shares of Rheinmetall from a “hold” rating to a “buy” rating in a research report on Monday, May 18th. Zacks Research cut shares of Rheinmetall from a “hold” rating to a “strong sell” rating in a research report on Wednesday, July 8th. Santander raised shares of Rheinmetall to an “outperform” rating in a research note on Monday, May 4th. Oddo Bhf upgraded shares of Rheinmetall to an “outperform” rating in a report on Monday, June 22nd. Finally, Jefferies Financial Group reaffirmed a “buy” rating on shares of Rheinmetall in a research note on Monday, April 20th. Eight investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.
Check Out Our Latest Analysis on RNMBY
Rheinmetall Trading Down 1.8%
About Rheinmetall
Rheinmetall AG is a Germany-based technology group specializing in defense and automotive solutions. Established in 1889 and headquartered in Düsseldorf, the company operates through two core divisions: Defense and Mobility (formerly Automotive). With a long heritage in engineering and manufacturing, Rheinmetall has evolved into a leading supplier of military vehicles, weapons systems and civilian mobility components, serving customers worldwide.
The Defense division develops and produces a broad portfolio of products and services for armed forces.
Featured Articles
- Five stocks we like better than Rheinmetall
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
- The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
- Why Micron Is Doubling Down While the HBM Shortage Persists
Receive News & Ratings for Rheinmetall Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rheinmetall and related companies with MarketBeat.com's FREE daily email newsletter.
